Sanofi Adr (SNY)

Mar 31, 2025

FDA Approves Sanofi's Hemophilia Drug - Benzinga

Mar 31, 2025

Mar 27, 2025

Led by Dupixent, Solid Immunology Position Helps Support Steady Long-Term Growth for Sanofi - Morningstar

Mar 27, 2025

Mar 27, 2025

4 healthcare stocks attractive on valuation and ESG risk - Morningstar Australia

Mar 27, 2025

Mar 18, 2025

SNY Quantitative Stock Analysis - Nasdaq

Mar 18, 2025

Mar 17, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Mar 17, 2025

Mar 13, 2025

Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.

Mar 13, 2025

Mar 12, 2025

Know Labs Inc (KNW) Stock: A Closer Look at the Market Potential - The News Heater

Mar 12, 2025

Mar 04, 2025

European Equities Traded in the US as ADRs Fall in Tuesday Trading - TradingView

Mar 04, 2025

Feb 27, 2025

Piper Sandler Shows Market Leadership With Jump To 83 RS Rating - Inkl

Feb 27, 2025

Feb 26, 2025

Sanofi ADR Shows Market Leadership With Jump To 82 RS Rating - Investor's Business Daily

Feb 26, 2025

Feb 25, 2025

Gold Field ADR Sees Its Composite Rating Rise To 99 - Inkl

Feb 25, 2025

Feb 24, 2025

ZEEKR Intelligent ADR Shows Rising Price Performance With Jump To 80 RS Rating - Inkl

Feb 24, 2025

Feb 17, 2025

Validea Detailed Fundamental AnalysisSNY - Nasdaq

Feb 17, 2025

Feb 14, 2025

Harrow Earns Relative Strength Rating Upgrade - Inkl

Feb 14, 2025

Feb 13, 2025

Sanofi ADR Earns RS Rating Upgrade - Investor's Business Daily

Feb 13, 2025

Feb 11, 2025

Newmont Earns RS Rating Upgrade - Inkl

Feb 11, 2025

Feb 07, 2025

What was Skechers U S A, Inc (SKX)’s performance in the last session? - US Post News

Feb 07, 2025

Feb 07, 2025

Sanofi ADR (SNY) requires closer examination - US Post News

Feb 07, 2025

Feb 05, 2025

Sanofi ADR (SNY): A Technical Analysis - The News Heater

Feb 05, 2025

Feb 05, 2025

GNPX’s Market Whiplash: -38.94% YTD Decline, -42.28% Plunge in 30 Days - The InvestChronicle

Feb 05, 2025

Feb 05, 2025

Applied Materials Inc’s Banking’s 100-Day Moving Average at 182.60: Will the Stock Break Through? - The InvestChronicle

Feb 05, 2025

Feb 05, 2025

ESPR’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Feb 05, 2025

Feb 04, 2025

Regeneron Pharmaceuticals Beats On Libtayo's Back, Unveils Dividend - Investor's Business Daily

Feb 04, 2025

Feb 03, 2025

Waltham biotech plans to raise $150M in IPO this week - The Business Journals

Feb 03, 2025

Jan 30, 2025

Sanofi Reports Strong Q4 Sales Growth, Plans €5 Billion Buyback in 2025 - GuruFocus.com

Jan 30, 2025

Jan 30, 2025

Sanofi ADR earnings beat by $0.53, revenue fell short of estimates - Investing.com South Africa

Jan 30, 2025

Jan 30, 2025

Sanofi ADR (SNY) Recovers 15.33% From Low: Are We There Yet? - Stocks Register

Jan 30, 2025

Jan 29, 2025

Sanofi: Informations relatives au nombre de droits de vote et d'actions - GlobeNewswire Inc.

Jan 29, 2025